Chief Operating Officer
Dr. Lawrence Klein
As Chief Operating Officer, Dr. Lawrence Klein has responsibility for corporate strategy, business development, alliance management, and program management across the company’s research and development portfolio. Since joining CRISPR in 2016, Lawrence was a key contributor in developing the company’s initial corporate strategy, and led the formation of a number of the company’s strategic collaborations. Before joining our company, Lawrence was an Associate Partner at McKinsey & Company where he was a leader in the biotech practice and served a number of biotechnology companies on a wide range of topics from strategy to operations. Lawrence received a Ph.D. from Stanford University, where he conducted research in the field of T cell immunology and published in several leading scientific journals. He also holds a B.S. from the University of Wisconsin at Madison.
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.